We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$202M
1-Year Est. Return
15.81%
This Fund
S&P 500
This Quarter
Est. Return
+8.29%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$695M
AUM Growth
–
Cap. Flow
+$902M
Cap. Flow
% of AUM
129.79%
Top 10 Holdings %
Top 10 Hldgs %
22.88%
Holding
959
New
957
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.9M |
| 2 |
Nordson
NDSN
|
+$40.3M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$36.7M |
| 4 |
DTE Energy
DTE
|
+$18.1M |
| 5 |
General Motors
GM
|
+$14.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.84% |
| 2 | Technology | 10.24% |
| 3 | Industrials | 8.78% |
| 4 | Financials | 8.55% |
| 5 | Consumer Discretionary | 8.52% |
Similar funds
4FG
BFA
PCMK
CWM
AFWM
HWMO
PCM
BSA
tru Independence's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for tru Independence, which disclosed 959 positions worth $695M. Its ten largest holdings account for 23% of the portfolio.
Its largest position is Bristol-Myers Squibb: 1,081,698 shares worth $49.3M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Technology and Industrials.
- tru Independence's largest Q4 2019 buy was Bristol-Myers Squibb: 1,081,698 shares worth $49.3M.
- tru Independence's ten largest holdings make up 23% of its $695M portfolio in Q4 2019.
- tru Independence disclosed 959 positions in Q4 2019, its first 13F filing on record.
Based on tru Independence's 13F filing for Q4 2019, filed 19 May 2020.